Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Customizing CRISPR-Cas PAM specificity with protein language models.

Nature biotechnology·2026
Same author

2026 Medicare Payment and CPT Coding Update: Progress for Primary Care but Long-Term Fix Needed.

Family practice management·2026
Same author

Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.

Brain : a journal of neurology·2025
Same author

Incubation with tau aggregates increases hippocampal circuit excitability and enhances long-term depression in acute mouse hippocampal slices.

Frontiers in neural circuits·2025
Same author

Design of highly functional genome editors by modelling CRISPR-Cas sequences.

Nature·2025
Same author

Dogs with sepsis are more hypercoagulable and have higher fibrinolysis inhibitor activities than dogs with non-septic systemic inflammation.

Frontiers in veterinary science·2025
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Aug 23, 2025

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

18.8K

A Validated Method to Prepare Stable Tau Oligomers.

Emily Hill1,2, Kevin G Moffat1, Mark J Wall1

  • 1School of Life Sciences, University of Warwick, Coventry, UK.

Methods in Molecular Biology (Clifton, N.J.)
|October 31, 2022
PubMed
Summary
This summary is machine-generated.

This study presents a reliable method for creating stable tau oligomers, crucial for understanding their role in neurodegenerative diseases like Alzheimer's. These characterized oligomers will aid research into tauopathies.

Keywords:
Alzheimer’s diseaseOligomerProtein expression and purificationStable oligomerTauTauopathies

More Related Videos

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.5K
Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
12:47

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

18.9K

Related Experiment Videos

Last Updated: Aug 23, 2025

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
09:49

In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening

Published on: November 20, 2018

18.8K
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.5K
Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins
12:47

Nuclear Magnetic Resonance Spectroscopy for the Identification of Multiple Phosphorylations of Intrinsically Disordered Proteins

Published on: December 27, 2016

18.9K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Tau oligomers are implicated in tauopathies, including Alzheimer's disease.
  • The precise mechanisms of tau oligomer-induced neuronal dysfunction remain largely unknown.
  • In vitro studies of tau oligomers are challenging due to their aggregation instability.

Purpose of the Study:

  • To develop and validate a method for producing stable, characterized tau oligomers.
  • To provide a reproducible protocol for generating tau oligomers for research.
  • To facilitate studies investigating tau oligomer mechanisms in tauopathies.

Main Methods:

  • A step-by-step protocol for tau oligomer production.
  • Structural characterization of the generated tau oligomers.
  • Validation of the method for use in various experimental models.

Main Results:

  • Successful production of stable tau oligomers.
  • Structurally characterized tau oligomers suitable for research.
  • A validated protocol enabling consistent tau oligomer generation.

Conclusions:

  • The described method yields stable and characterized tau oligomers.
  • This protocol overcomes limitations of previous in vitro tau studies.
  • The method supports further investigation into tau oligomer function in tauopathies.